About Guardant Health
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched liquid biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.
|
|
|
1,001-5,000 employees
View all Guardant Health employees
|
|
Biotechnology
|
|
3100 Hanover Street, Palo Alto, California 94304, US
|
|
2012
|
Guardant Health Alternatives
Frequently Asked Questions about Guardant Health
Lorin Doran is the CEO of Guardant Health. To contact Lorin Doran email at [email protected] or [email protected].
The decision makers in Guardant Health are Amelia Masui Merrill, Benjamin Gannon, Blanca Trujillo, etc. Click to Find Guardant Health decision makers emails.
Guardant Health Staff Directory
Search Guardant Health Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
